Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib may help regrow hair in alopecia areata patients.

Etanercept effectively treated a severe skin condition when other treatments failed.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Provenge extends prostate cancer survival by about 4 months.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

The combination therapy was effective and well-tolerated, especially in young patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Cetuximab can cause skin cysts after acne-like eruptions.

FDG PET/CT can improve cancer treatment plans in dogs.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Dutasteride may help shrink prostate cancer tumors.